Literature DB >> 11474224

Urinary copper excretion in type 2 diabetic patients with nephropathy.

S Ito1, H Fujita, T Narita, T Yaginuma, Y Kawarada, M Kawagoe, T Sugiyama.   

Abstract

BACKGROUND/AIMS: The aim of this study was to examine the relationship between the degree of urinary copper excretion and stages of diabetic nephropathy.
METHODS: Copper, ceruloplasmin and albumin concentrations were measured in serum and urine samples from 41 type 2 diabetic outpatients with different stages of nephropathy and from 10 healthy controls. The copper/albumin and copper/ceruloplasmin ratios in serum and urine were determined. Furthermore, we examined whether free copper ions are dissociated from ceruloplasmin under various pH conditions.
RESULTS: Urinary copper concentrations significantly increased only in macroalbuminuric patients. The copper/ceruloplasmin and copper/albumin ratios in urine were consistently greater than those in serum which were not different between patients and healthy controls except the copper/albumin ratio in macroalbuminuric patients. The ratios in urine decreased in parallel with the progression of nephropathy. Copper was found to be released from ceruloplasmin under acidic conditions.
CONCLUSION: Urinary copper excretion in healthy controls may be the result of dissociation from the albumin-copper complex of serum during its passage through the kidney. In diabetic patients with advanced nephropathy, urinary copper excretion may be due to dissociations from both copper-albumin and ceruloplasmin-copper complexes filtered through the damaged glomerulus. Overloading of urinary copper to damaged renal tubules may play some roles in the progression of nephropathy in patients with advanced nephropathy. Copyright 2001 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11474224     DOI: 10.1159/000046013

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  10 in total

1.  Adjusting copper concentrations for caeruloplasmin levels in routine clinical practice.

Authors:  P J Twomey; A Viljoen; I M House; T M Reynolds; A S Wierzbicki
Journal:  J Clin Pathol       Date:  2006-04-27       Impact factor: 3.411

2.  Copper:caeruloplasmin ratio.

Authors:  Patrick J Twomey; Adie Viljoen; Ivan M House; Timothy M Reynolds; Anthony S Wierzbicki
Journal:  J Clin Pathol       Date:  2007-04       Impact factor: 3.411

Review 3.  Therapeutic potential of copper chelation with triethylenetetramine in managing diabetes mellitus and Alzheimer's disease.

Authors:  Garth J S Cooper
Journal:  Drugs       Date:  2011-07-09       Impact factor: 9.546

4.  [ 64Cu]Cu-Albumin Clearance Imaging to Evaluate Lymphatic Efflux of Cerebrospinal Space Fluid in Mouse Model.

Authors:  Azmal Sarker; Minseok Suh; Yoori Choi; Ji Yong Park; Seokjun Kwon; Hyun Kim; Eunji Lee; Hyeyeon Seo; Yun-Sang Lee; Dong Soo Lee
Journal:  Nucl Med Mol Imaging       Date:  2022-04-02

5.  A copper(II)-selective chelator ameliorates diabetes-evoked renal fibrosis and albuminuria, and suppresses pathogenic TGF-beta activation in the kidneys of rats used as a model of diabetes.

Authors:  D Gong; J Lu; X Chen; S Reddy; D J Crossman; S Glyn-Jones; Y-S Choong; J Kennedy; B Barry; S Zhang; Y-K Chan; K Ruggiero; A R J Phillips; G J S Cooper
Journal:  Diabetologia       Date:  2008-07-18       Impact factor: 10.122

6.  Correlation between microalbuminuria and urinary copper in type two diabetic patients.

Authors:  Afsaneh Talaei; Saber Jabari; Mohamad Hasan Bigdeli; Heidar Farahani; Mansour Siavash
Journal:  Indian J Endocrinol Metab       Date:  2011-10

7.  Cardiovascular effects of copper deficiency on activity of superoxide dismutase in diabetic nephropathy.

Authors:  Mohammed A Al-Bayati; Dina A Jamil; Hayder A Al-Aubaidy
Journal:  N Am J Med Sci       Date:  2015-02

8.  Diabetes and Alzheimer's Disease: Can Elevated Free Copper Predict the Risk of the Disease?

Authors:  Rosanna Squitti; Armando J Mendez; Ilaria Simonelli; Camillo Ricordi
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 9.  The Molecular Mechanisms of Defective Copper Metabolism in Diabetic Cardiomyopathy.

Authors:  Xiangning Cui; Yan Wang; Han Liu; Mengjun Shi; Jingwu Wang; Yifei Wang
Journal:  Oxid Med Cell Longev       Date:  2022-10-04       Impact factor: 7.310

10.  The Application of SILAC Mouse in Human Body Fluid Proteomics Analysis Reveals Protein Patterns Associated with IgA Nephropathy.

Authors:  Shilin Zhao; Rongxia Li; Xiaofan Cai; Wanjia Chen; Qingrun Li; Tao Xing; Wenjie Zhu; Y Eugene Chen; Rong Zeng; Yueyi Deng
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-15       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.